0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gabapentin Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-16D300
Home | Category |Health |Pharmacy |Drugs & Medications
Global Gabapentin Market Insights Forecast to 2025

Global Gabapentin Market Insights, Forecast to 2025

Code: QYRE-Auto-16D300
Report
May 2019
125 Pages
QYResearch
Region: Global, Europe, North America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.
Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
The global Gabapentin market is valued at 1430 million US$ in 2018 and will reach 1630 million US$ by the end of 2025, growing at a CAGR of 1.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gabapentin market based on company, product type, end user and key regions.

This report studies the global market size of Gabapentin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gabapentin in these regions.
This research report categorizes the global Gabapentin market by top players/brands, region, type and end user. This report also studies the global Gabapentin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Pfizer
    Depomed
    TEVA
    Mylan
    Arbor Pharma
    Novartis
    Apotex
    Sun Pharmaceutical
    Aurobindo Pharma
    Intas
    Amneal
    Marksans Pharma
    Glenmark
    Alkem
    Jiangsu Enhua
    Jiangsu Hengrui
    Sailike

Market size by Product
    Capsule
    Tablet
Market size by End User
    Epilepsy
    Neuropathic Pain
    Restless Legs Syndrome
    Others

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Gabapentin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Gabapentin market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Gabapentin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Gabapentin submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Gabapentin are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gabapentin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Gabapentin Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Gabapentin Market Size Growth Rate by Product
        1.4.2 Capsule
        1.4.3 Tablet
    1.5 Market by End User
        1.5.1 Global Gabapentin Market Size Growth Rate by End User
        1.5.2 Epilepsy
        1.5.3 Neuropathic Pain
        1.5.4 Restless Legs Syndrome
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Gabapentin Market Size
        2.1.1 Global Gabapentin Revenue 2014-2025
        2.1.2 Global Gabapentin Sales 2014-2025
    2.2 Gabapentin Growth Rate by Regions
        2.2.1 Global Gabapentin Sales by Regions
        2.2.2 Global Gabapentin Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Gabapentin Sales by Manufacturers
        3.1.1 Gabapentin Sales by Manufacturers
        3.1.2 Gabapentin Sales Market Share by Manufacturers
        3.1.3 Global Gabapentin Market Concentration Ratio (CR5 and HHI)
    3.2 Gabapentin Revenue by Manufacturers
        3.2.1 Gabapentin Revenue by Manufacturers (2014-2019)
        3.2.2 Gabapentin Revenue Share by Manufacturers (2014-2019)
    3.3 Gabapentin Price by Manufacturers
    3.4 Gabapentin Manufacturing Base Distribution, Product Types
        3.4.1 Gabapentin Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Gabapentin Product Type
        3.4.3 Date of International Manufacturers Enter into Gabapentin Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Gabapentin Sales by Product
    4.2 Global Gabapentin Revenue by Product
    4.3 Gabapentin Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Gabapentin Breakdown Data by End User

6 North America
    6.1 North America Gabapentin by Countries
        6.1.1 North America Gabapentin Sales by Countries
        6.1.2 North America Gabapentin Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Gabapentin by Product
    6.3 North America Gabapentin by End User

7 Europe
    7.1 Europe Gabapentin by Countries
        7.1.1 Europe Gabapentin Sales by Countries
        7.1.2 Europe Gabapentin Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Gabapentin by Product
    7.3 Europe Gabapentin by End User

8 Asia Pacific
    8.1 Asia Pacific Gabapentin by Countries
        8.1.1 Asia Pacific Gabapentin Sales by Countries
        8.1.2 Asia Pacific Gabapentin Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Gabapentin by Product
    8.3 Asia Pacific Gabapentin by End User

9 Central & South America
    9.1 Central & South America Gabapentin by Countries
        9.1.1 Central & South America Gabapentin Sales by Countries
        9.1.2 Central & South America Gabapentin Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Gabapentin by Product
    9.3 Central & South America Gabapentin by End User

10 Middle East and Africa
    10.1 Middle East and Africa Gabapentin by Countries
        10.1.1 Middle East and Africa Gabapentin Sales by Countries
        10.1.2 Middle East and Africa Gabapentin Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Gabapentin by Product
    10.3 Middle East and Africa Gabapentin by End User

11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Company Business Overview
        11.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Pfizer Gabapentin Products Offered
        11.1.5 Pfizer Recent Development
    11.2 Depomed
        11.2.1 Depomed Company Details
        11.2.2 Company Business Overview
        11.2.3 Depomed Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Depomed Gabapentin Products Offered
        11.2.5 Depomed Recent Development
    11.3 TEVA
        11.3.1 TEVA Company Details
        11.3.2 Company Business Overview
        11.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 TEVA Gabapentin Products Offered
        11.3.5 TEVA Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Company Business Overview
        11.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Mylan Gabapentin Products Offered
        11.4.5 Mylan Recent Development
    11.5 Arbor Pharma
        11.5.1 Arbor Pharma Company Details
        11.5.2 Company Business Overview
        11.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Arbor Pharma Gabapentin Products Offered
        11.5.5 Arbor Pharma Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Company Business Overview
        11.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Novartis Gabapentin Products Offered
        11.6.5 Novartis Recent Development
    11.7 Apotex
        11.7.1 Apotex Company Details
        11.7.2 Company Business Overview
        11.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Apotex Gabapentin Products Offered
        11.7.5 Apotex Recent Development
    11.8 Sun Pharmaceutical
        11.8.1 Sun Pharmaceutical Company Details
        11.8.2 Company Business Overview
        11.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Sun Pharmaceutical Gabapentin Products Offered
        11.8.5 Sun Pharmaceutical Recent Development
    11.9 Aurobindo Pharma
        11.9.1 Aurobindo Pharma Company Details
        11.9.2 Company Business Overview
        11.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Aurobindo Pharma Gabapentin Products Offered
        11.9.5 Aurobindo Pharma Recent Development
    11.10 Intas
        11.10.1 Intas Company Details
        11.10.2 Company Business Overview
        11.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Intas Gabapentin Products Offered
        11.10.5 Intas Recent Development
    11.11 Amneal
    11.12 Marksans Pharma
    11.13 Glenmark
    11.14 Alkem
    11.15 Jiangsu Enhua
    11.16 Jiangsu Hengrui
    11.17 Sailike

12 Future Forecast
    12.1 Gabapentin Market Forecast by Regions
        12.1.1 Global Gabapentin Sales Forecast by Regions 2019-2025
        12.1.2 Global Gabapentin Revenue Forecast by Regions 2019-2025
    12.2 Gabapentin Market Forecast by Product
        12.2.1 Global Gabapentin Sales Forecast by Product 2019-2025
        12.2.2 Global Gabapentin Revenue Forecast by Product 2019-2025
    12.3 Gabapentin Market Forecast by End User
    12.4 North America Gabapentin Forecast
    12.5 Europe Gabapentin Forecast
    12.6 Asia Pacific Gabapentin Forecast
    12.7 Central & South America Gabapentin Forecast
    12.8 Middle East and Africa Gabapentin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Gabapentin Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Gabapentin Product Picture
    Table Gabapentin Market Segments
    Table Key Manufacturers Gabapentin Covered
    Table Global Gabapentin Market Size Growth Rate by Product 2019-2025 (M Units) & (Million US$)
    Figure Global Gabapentin Sales Market Share by Product 2014-2025
    Figure Capsule Product Picture
    Table Major Manufacturers of Capsule
    Figure Tablet Product Picture
    Table Major Manufacturers of Tablet
    Table Global Gabapentin Market Size Growth Rate by End User 2019-2025 (M Units)
    Figure Epilepsy
    Figure Neuropathic Pain
    Figure Restless Legs Syndrome
    Figure Others
    Figure Gabapentin Report Years Considered
    Figure Global Gabapentin Market Size 2014-2025 (Million US$)
    Figure Global Gabapentin Sales 2014-2025 (M Units)
    Table Global Gabapentin Market Size by Regions 2014-2019 (M Units) & (Million US$)
    Table Global Gabapentin Sales by Regions 2014-2019 (M Units)
    Table Global Gabapentin Sales Market Share by Regions 2014-2019
    Figure Global Gabapentin Sales Market Share by Regions 2014-2019
    Figure 2018 Global Gabapentin Sales Market Share by Regions
    Table Global Gabapentin Revenue by Regions 2014-2019 (Million US$)
    Table Global Gabapentin Revenue Market Share by Regions 2014-2019
    Figure Global Gabapentin Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Gabapentin Revenue Market Share by Regions
    Table Global Gabapentin Sales by Manufacturers (2014-2019) (M Units)
    Table Global Gabapentin Sales Share by Manufacturers (2014-2019)
    Figure Global Gabapentin Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Gabapentin Revenue by Manufacturers (2014-2019) (Million USD)
    Table Gabapentin Revenue Share by Manufacturers (2014-2019)
    Figure Gabapentin Value Share by Manufacturers in 2018
    Table Key Manufacturers Gabapentin Price (2014-2019) (USD/K Unit)
    Table Gabapentin Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Gabapentin Product Type
    Table Date of International Manufacturers Enter into Gabapentin Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Gabapentin Sales by Product (2014-2019) (M Units)
    Table Global Gabapentin Sales Share by Product (2014-2019)
    Figure Global Gabapentin Sales Market Share by Product (2014-2019)
    Figure Global Gabapentin Sales Market Share by Product in 2018
    Table Global Gabapentin Revenue by Product (2014-2019) (Million US$)
    Table Global Gabapentin Revenue Share by Product (2014-2019)
    Figure Global Gabapentin Revenue Market Share by Product (2014-2019)
    Figure Global Gabapentin Revenue Market Share by Product in 2018
    Table Gabapentin Price by Product 2014-2019 (USD/K Unit)
    Table Global Gabapentin Sales by End User (2014-2019) (M Units)
    Table Global Gabapentin Sales Share by End User (2014-2019)
    Figure Global Sales Gabapentin Market Share by End User (2014-2019)
    Figure Global Sales Gabapentin Market Share by End User in 2018
    Figure North America Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure North America Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Gabapentin Sales by Countries (2014-2019) (M Units)
    Table North America Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Gabapentin Sales Market Share by Countries
    Table North America Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table North America Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Gabapentin Revenue Market Share by Countries
    Figure United States Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure United States Gabapentin Revenue Growth Rate (2014-2019) (M Units)
    Figure Canada Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Canada Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Mexico Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Gabapentin Sales by Product (2014-2019) (M Units)
    Table North America Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 North America Gabapentin Market Share by Product
    Table North America Gabapentin Sales by End User (2014-2019) (M Units)
    Table North America Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 North America Gabapentin Market Share by End User
    Figure Europe Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Europe Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Europe Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Gabapentin Sales Market Share by Countries
    Table Europe Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Europe Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Gabapentin Revenue Market Share by Countries
    Figure Germany Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Germany Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure France Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure UK Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Italy Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Russia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Gabapentin Sales by Product (2014-2019) (M Units)
    Table Europe Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Gabapentin Market Share by Product
    Table Europe Gabapentin Sales by End User (2014-2019) (M Units)
    Table Europe Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Gabapentin Market Share by End User
    Figure Asia Pacific Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Asia Pacific Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Asia Pacific Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Sales Market Share by Countries
    Table Asia Pacific Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Revenue Market Share by Countries
    Figure China Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure China Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Japan Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Korea Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure India Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Australia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Indonesia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Malaysia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Philippines Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Thailand Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Vietnam Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Singapore Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Gabapentin Sales by Product (2014-2019) (M Units)
    Table Asia Pacific Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Market Share by Product
    Table Asia Pacific Gabapentin Sales by End User (2014-2019) (M Units)
    Table Asia Pacific Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Market Share by End User
    Figure Central & South America Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Central & South America Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Central & South America Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Gabapentin Sales Market Share by Countries
    Table Central & South America Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Gabapentin Revenue Market Share by Countries
    Figure Brazil Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Brazil Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Argentina Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Gabapentin Sales by Product (2014-2019) (M Units)
    Table Central & South America Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Gabapentin Market Share by Product
    Table Central & South America Gabapentin Sales by End User (2014-2019) (M Units)
    Table Central & South America Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Gabapentin Market Share by End User
    Figure Middle East and Africa Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Middle East and Africa Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Middle East and Africa Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Sales Market Share by Countries
    Table Middle East and Africa Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Revenue Market Share by Countries
    Figure GCC Countries Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure GCC Countries Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Turkey Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Egypt Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure South Africa Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Gabapentin Sales by Product (2014-2019) (M Units)
    Table Middle East and Africa Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Market Share by Product
    Table Middle East and Africa Gabapentin Sales by End User (2014-2019) (M Units)
    Table Middle East and Africa Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Market Share by End User
    Table Pfizer Company Details
    Table Pfizer Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Pfizer Recent Development
    Table Depomed Company Details
    Table Depomed Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Depomed Recent Development
    Table TEVA Company Details
    Table TEVA Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table TEVA Recent Development
    Table Mylan Company Details
    Table Mylan Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Mylan Recent Development
    Table Arbor Pharma Company Details
    Table Arbor Pharma Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Arbor Pharma Recent Development
    Table Novartis Company Details
    Table Novartis Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Novartis Recent Development
    Table Apotex Company Details
    Table Apotex Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Apotex Recent Development
    Table Sun Pharmaceutical Company Details
    Table Sun Pharmaceutical Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Sun Pharmaceutical Recent Development
    Table Aurobindo Pharma Company Details
    Table Aurobindo Pharma Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Aurobindo Pharma Recent Development
    Table Intas Company Details
    Table Intas Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Intas Recent Development
    Table Amneal Company Details
    Table Marksans Pharma Company Details
    Table Glenmark Company Details
    Table Alkem Company Details
    Table Jiangsu Enhua Company Details
    Table Jiangsu Hengrui Company Details
    Table Sailike Company Details
    Table Global Gabapentin Sales Forecast by Regions 2019-2025 (M Units)
    Table Global Gabapentin Sales Market Share Forecast by Regions 2019-2025
    Table Global Gabapentin Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Gabapentin Revenue Market Share Forecast by Regions 2019-2025
    Table Global Gabapentin Sales Forecast by Product 2019-2025 (M Units)
    Table Global Gabapentin Sales Market Share Forecast by Product 2019-2025
    Table Global Gabapentin Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Gabapentin Revenue Market Share Forecast by Product 2019-2025
    Table Global Gabapentin Sales Forecast by End User 2019-2025 (M Units)
    Table Global Gabapentin Sales Market Share Forecast by End User 2019-2025
    Figure North America Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure North America Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Europe Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Asia Pacific Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Central & South America Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Middle East and Africa Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Gabapentin Value Chain
    Table Gabapentin Customers List
    Table Gabapentin Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.
Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
The global Gabapentin market is valued at 1430 million US$ in 2018 and will reach 1630 million US$ by the end of 2025, growing at a CAGR of 1.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gabapentin market based on company, product type, end user and key regions.

This report studies the global market size of Gabapentin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gabapentin in these regions.
This research report categorizes the global Gabapentin market by top players/brands, region, type and end user. This report also studies the global Gabapentin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Pfizer
    Depomed
    TEVA
    Mylan
    Arbor Pharma
    Novartis
    Apotex
    Sun Pharmaceutical
    Aurobindo Pharma
    Intas
    Amneal
    Marksans Pharma
    Glenmark
    Alkem
    Jiangsu Enhua
    Jiangsu Hengrui
    Sailike

Market size by Product
    Capsule
    Tablet
Market size by End User
    Epilepsy
    Neuropathic Pain
    Restless Legs Syndrome
    Others

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Gabapentin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Gabapentin market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Gabapentin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Gabapentin submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Gabapentin are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gabapentin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents

1 Study Coverage
    1.1 Gabapentin Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Gabapentin Market Size Growth Rate by Product
        1.4.2 Capsule
        1.4.3 Tablet
    1.5 Market by End User
        1.5.1 Global Gabapentin Market Size Growth Rate by End User
        1.5.2 Epilepsy
        1.5.3 Neuropathic Pain
        1.5.4 Restless Legs Syndrome
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Gabapentin Market Size
        2.1.1 Global Gabapentin Revenue 2014-2025
        2.1.2 Global Gabapentin Sales 2014-2025
    2.2 Gabapentin Growth Rate by Regions
        2.2.1 Global Gabapentin Sales by Regions
        2.2.2 Global Gabapentin Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Gabapentin Sales by Manufacturers
        3.1.1 Gabapentin Sales by Manufacturers
        3.1.2 Gabapentin Sales Market Share by Manufacturers
        3.1.3 Global Gabapentin Market Concentration Ratio (CR5 and HHI)
    3.2 Gabapentin Revenue by Manufacturers
        3.2.1 Gabapentin Revenue by Manufacturers (2014-2019)
        3.2.2 Gabapentin Revenue Share by Manufacturers (2014-2019)
    3.3 Gabapentin Price by Manufacturers
    3.4 Gabapentin Manufacturing Base Distribution, Product Types
        3.4.1 Gabapentin Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Gabapentin Product Type
        3.4.3 Date of International Manufacturers Enter into Gabapentin Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Gabapentin Sales by Product
    4.2 Global Gabapentin Revenue by Product
    4.3 Gabapentin Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Gabapentin Breakdown Data by End User

6 North America
    6.1 North America Gabapentin by Countries
        6.1.1 North America Gabapentin Sales by Countries
        6.1.2 North America Gabapentin Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Gabapentin by Product
    6.3 North America Gabapentin by End User

7 Europe
    7.1 Europe Gabapentin by Countries
        7.1.1 Europe Gabapentin Sales by Countries
        7.1.2 Europe Gabapentin Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Gabapentin by Product
    7.3 Europe Gabapentin by End User

8 Asia Pacific
    8.1 Asia Pacific Gabapentin by Countries
        8.1.1 Asia Pacific Gabapentin Sales by Countries
        8.1.2 Asia Pacific Gabapentin Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Gabapentin by Product
    8.3 Asia Pacific Gabapentin by End User

9 Central & South America
    9.1 Central & South America Gabapentin by Countries
        9.1.1 Central & South America Gabapentin Sales by Countries
        9.1.2 Central & South America Gabapentin Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Gabapentin by Product
    9.3 Central & South America Gabapentin by End User

10 Middle East and Africa
    10.1 Middle East and Africa Gabapentin by Countries
        10.1.1 Middle East and Africa Gabapentin Sales by Countries
        10.1.2 Middle East and Africa Gabapentin Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Gabapentin by Product
    10.3 Middle East and Africa Gabapentin by End User

11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Company Business Overview
        11.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Pfizer Gabapentin Products Offered
        11.1.5 Pfizer Recent Development
    11.2 Depomed
        11.2.1 Depomed Company Details
        11.2.2 Company Business Overview
        11.2.3 Depomed Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Depomed Gabapentin Products Offered
        11.2.5 Depomed Recent Development
    11.3 TEVA
        11.3.1 TEVA Company Details
        11.3.2 Company Business Overview
        11.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 TEVA Gabapentin Products Offered
        11.3.5 TEVA Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Company Business Overview
        11.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Mylan Gabapentin Products Offered
        11.4.5 Mylan Recent Development
    11.5 Arbor Pharma
        11.5.1 Arbor Pharma Company Details
        11.5.2 Company Business Overview
        11.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Arbor Pharma Gabapentin Products Offered
        11.5.5 Arbor Pharma Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Company Business Overview
        11.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Novartis Gabapentin Products Offered
        11.6.5 Novartis Recent Development
    11.7 Apotex
        11.7.1 Apotex Company Details
        11.7.2 Company Business Overview
        11.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Apotex Gabapentin Products Offered
        11.7.5 Apotex Recent Development
    11.8 Sun Pharmaceutical
        11.8.1 Sun Pharmaceutical Company Details
        11.8.2 Company Business Overview
        11.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Sun Pharmaceutical Gabapentin Products Offered
        11.8.5 Sun Pharmaceutical Recent Development
    11.9 Aurobindo Pharma
        11.9.1 Aurobindo Pharma Company Details
        11.9.2 Company Business Overview
        11.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Aurobindo Pharma Gabapentin Products Offered
        11.9.5 Aurobindo Pharma Recent Development
    11.10 Intas
        11.10.1 Intas Company Details
        11.10.2 Company Business Overview
        11.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Intas Gabapentin Products Offered
        11.10.5 Intas Recent Development
    11.11 Amneal
    11.12 Marksans Pharma
    11.13 Glenmark
    11.14 Alkem
    11.15 Jiangsu Enhua
    11.16 Jiangsu Hengrui
    11.17 Sailike

12 Future Forecast
    12.1 Gabapentin Market Forecast by Regions
        12.1.1 Global Gabapentin Sales Forecast by Regions 2019-2025
        12.1.2 Global Gabapentin Revenue Forecast by Regions 2019-2025
    12.2 Gabapentin Market Forecast by Product
        12.2.1 Global Gabapentin Sales Forecast by Product 2019-2025
        12.2.2 Global Gabapentin Revenue Forecast by Product 2019-2025
    12.3 Gabapentin Market Forecast by End User
    12.4 North America Gabapentin Forecast
    12.5 Europe Gabapentin Forecast
    12.6 Asia Pacific Gabapentin Forecast
    12.7 Central & South America Gabapentin Forecast
    12.8 Middle East and Africa Gabapentin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Gabapentin Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
Read More
List of Tables and Figures

    Figure Gabapentin Product Picture
    Table Gabapentin Market Segments
    Table Key Manufacturers Gabapentin Covered
    Table Global Gabapentin Market Size Growth Rate by Product 2019-2025 (M Units) & (Million US$)
    Figure Global Gabapentin Sales Market Share by Product 2014-2025
    Figure Capsule Product Picture
    Table Major Manufacturers of Capsule
    Figure Tablet Product Picture
    Table Major Manufacturers of Tablet
    Table Global Gabapentin Market Size Growth Rate by End User 2019-2025 (M Units)
    Figure Epilepsy
    Figure Neuropathic Pain
    Figure Restless Legs Syndrome
    Figure Others
    Figure Gabapentin Report Years Considered
    Figure Global Gabapentin Market Size 2014-2025 (Million US$)
    Figure Global Gabapentin Sales 2014-2025 (M Units)
    Table Global Gabapentin Market Size by Regions 2014-2019 (M Units) & (Million US$)
    Table Global Gabapentin Sales by Regions 2014-2019 (M Units)
    Table Global Gabapentin Sales Market Share by Regions 2014-2019
    Figure Global Gabapentin Sales Market Share by Regions 2014-2019
    Figure 2018 Global Gabapentin Sales Market Share by Regions
    Table Global Gabapentin Revenue by Regions 2014-2019 (Million US$)
    Table Global Gabapentin Revenue Market Share by Regions 2014-2019
    Figure Global Gabapentin Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Gabapentin Revenue Market Share by Regions
    Table Global Gabapentin Sales by Manufacturers (2014-2019) (M Units)
    Table Global Gabapentin Sales Share by Manufacturers (2014-2019)
    Figure Global Gabapentin Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Gabapentin Revenue by Manufacturers (2014-2019) (Million USD)
    Table Gabapentin Revenue Share by Manufacturers (2014-2019)
    Figure Gabapentin Value Share by Manufacturers in 2018
    Table Key Manufacturers Gabapentin Price (2014-2019) (USD/K Unit)
    Table Gabapentin Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Gabapentin Product Type
    Table Date of International Manufacturers Enter into Gabapentin Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Gabapentin Sales by Product (2014-2019) (M Units)
    Table Global Gabapentin Sales Share by Product (2014-2019)
    Figure Global Gabapentin Sales Market Share by Product (2014-2019)
    Figure Global Gabapentin Sales Market Share by Product in 2018
    Table Global Gabapentin Revenue by Product (2014-2019) (Million US$)
    Table Global Gabapentin Revenue Share by Product (2014-2019)
    Figure Global Gabapentin Revenue Market Share by Product (2014-2019)
    Figure Global Gabapentin Revenue Market Share by Product in 2018
    Table Gabapentin Price by Product 2014-2019 (USD/K Unit)
    Table Global Gabapentin Sales by End User (2014-2019) (M Units)
    Table Global Gabapentin Sales Share by End User (2014-2019)
    Figure Global Sales Gabapentin Market Share by End User (2014-2019)
    Figure Global Sales Gabapentin Market Share by End User in 2018
    Figure North America Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure North America Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Gabapentin Sales by Countries (2014-2019) (M Units)
    Table North America Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Gabapentin Sales Market Share by Countries
    Table North America Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table North America Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Gabapentin Revenue Market Share by Countries
    Figure United States Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure United States Gabapentin Revenue Growth Rate (2014-2019) (M Units)
    Figure Canada Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Canada Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Mexico Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Gabapentin Sales by Product (2014-2019) (M Units)
    Table North America Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 North America Gabapentin Market Share by Product
    Table North America Gabapentin Sales by End User (2014-2019) (M Units)
    Table North America Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 North America Gabapentin Market Share by End User
    Figure Europe Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Europe Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Europe Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Gabapentin Sales Market Share by Countries
    Table Europe Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Europe Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Gabapentin Revenue Market Share by Countries
    Figure Germany Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Germany Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure France Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure UK Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Italy Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Russia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Gabapentin Sales by Product (2014-2019) (M Units)
    Table Europe Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Gabapentin Market Share by Product
    Table Europe Gabapentin Sales by End User (2014-2019) (M Units)
    Table Europe Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Gabapentin Market Share by End User
    Figure Asia Pacific Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Asia Pacific Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Asia Pacific Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Sales Market Share by Countries
    Table Asia Pacific Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Revenue Market Share by Countries
    Figure China Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure China Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Japan Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Korea Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure India Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Australia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Indonesia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Malaysia Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Philippines Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Thailand Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Vietnam Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Singapore Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Gabapentin Sales by Product (2014-2019) (M Units)
    Table Asia Pacific Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Market Share by Product
    Table Asia Pacific Gabapentin Sales by End User (2014-2019) (M Units)
    Table Asia Pacific Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Gabapentin Market Share by End User
    Figure Central & South America Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Central & South America Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Central & South America Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Gabapentin Sales Market Share by Countries
    Table Central & South America Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Gabapentin Revenue Market Share by Countries
    Figure Brazil Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Brazil Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Argentina Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Gabapentin Sales by Product (2014-2019) (M Units)
    Table Central & South America Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Gabapentin Market Share by Product
    Table Central & South America Gabapentin Sales by End User (2014-2019) (M Units)
    Table Central & South America Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Gabapentin Market Share by End User
    Figure Middle East and Africa Gabapentin Sales Growth Rate 2014-2019 (M Units)
    Figure Middle East and Africa Gabapentin Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Gabapentin Sales by Countries (2014-2019) (M Units)
    Table Middle East and Africa Gabapentin Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Sales Market Share by Countries
    Table Middle East and Africa Gabapentin Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Gabapentin Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Revenue Market Share by Countries
    Figure GCC Countries Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure GCC Countries Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Turkey Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure Egypt Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Gabapentin Sales Growth Rate (2014-2019) (M Units)
    Figure South Africa Gabapentin Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Gabapentin Sales by Product (2014-2019) (M Units)
    Table Middle East and Africa Gabapentin Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Market Share by Product
    Table Middle East and Africa Gabapentin Sales by End User (2014-2019) (M Units)
    Table Middle East and Africa Gabapentin Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Gabapentin Market Share by End User
    Table Pfizer Company Details
    Table Pfizer Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Pfizer Recent Development
    Table Depomed Company Details
    Table Depomed Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Depomed Recent Development
    Table TEVA Company Details
    Table TEVA Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table TEVA Recent Development
    Table Mylan Company Details
    Table Mylan Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Mylan Recent Development
    Table Arbor Pharma Company Details
    Table Arbor Pharma Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Arbor Pharma Recent Development
    Table Novartis Company Details
    Table Novartis Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Novartis Recent Development
    Table Apotex Company Details
    Table Apotex Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Apotex Recent Development
    Table Sun Pharmaceutical Company Details
    Table Sun Pharmaceutical Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Sun Pharmaceutical Recent Development
    Table Aurobindo Pharma Company Details
    Table Aurobindo Pharma Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Aurobindo Pharma Recent Development
    Table Intas Company Details
    Table Intas Gabapentin Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2014-2019)
    Table Intas Recent Development
    Table Amneal Company Details
    Table Marksans Pharma Company Details
    Table Glenmark Company Details
    Table Alkem Company Details
    Table Jiangsu Enhua Company Details
    Table Jiangsu Hengrui Company Details
    Table Sailike Company Details
    Table Global Gabapentin Sales Forecast by Regions 2019-2025 (M Units)
    Table Global Gabapentin Sales Market Share Forecast by Regions 2019-2025
    Table Global Gabapentin Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Gabapentin Revenue Market Share Forecast by Regions 2019-2025
    Table Global Gabapentin Sales Forecast by Product 2019-2025 (M Units)
    Table Global Gabapentin Sales Market Share Forecast by Product 2019-2025
    Table Global Gabapentin Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Gabapentin Revenue Market Share Forecast by Product 2019-2025
    Table Global Gabapentin Sales Forecast by End User 2019-2025 (M Units)
    Table Global Gabapentin Sales Market Share Forecast by End User 2019-2025
    Figure North America Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure North America Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Europe Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Asia Pacific Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Central & South America Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Gabapentin Sales Growth Rate Forecast (2019-2025) (M Units)
    Figure Middle East and Africa Gabapentin Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Gabapentin Value Chain
    Table Gabapentin Customers List
    Table Gabapentin Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Paclitaxel Injection Market Research Report 2021
Global Paclitaxel Injection Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-5J4435
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Myotonic Dystrophy Medication Market Size Status and Forecast 2021 2027
Global Myotonic Dystrophy Medication Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10R4400
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Acne Treatment Drug Market Size Status and Forecast 2021 2027
Global Acne Treatment Drug Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10B4399
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Coronavirus Treatment Drugs Market Size Status and Forecast 2021 2027
Global Coronavirus Treatment Drugs Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-37M4166
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0